Skip to main content
Top
Published in: International Journal of Hematology 5/2011

01-11-2011 | Case Report

Glomerular hemophagocytic macrophages in a patient with proteinuria and clinical and laboratory features of hemophagocytic lymphohistiocytosis (HLH)

Authors: Ling Cao, William Dean Wallace, Shahrooz Eshaghian, Yuliya Linhares, Victor J. Marder

Published in: International Journal of Hematology | Issue 5/2011

Login to get access

Abstract

Hemophagocytic lymphohistiocytosis (HLH) is a heterogeneous disorder characterized by excessive activation and proliferation of nonmalignant histiocytes, which are commonly found in bone marrow, lymph nodes, spleen and liver in affected patients. Here, we report the presence of glomerular macrophages, including one showing erythrophagocytosis, on renal biopsy in a 25-year-old patient with clinical presentation and laboratory changes consistent with HLH. The clinical course was marked by persistent fever for 2 months, pleural and pericardial effusion, splenomegaly, lymphadenopathy, pancytopenia, cardiac arrhythmias, multiple organ dysfunction, and proteinuria, with demise after a 2-month hospitalization. Positive assay for Epstein–Barr virus (EBV), marked hyperferritinemia, hypofibrinogenemia, hypertriglyceridemia, elevated anti-nuclear antibody, proteinuria, and decreased circulating NK cells by flow cytometry were compatible with the diagnosis of HLH. We suggest that the glomerular hemophagocytic macrophages, which have not heretofore been described in the kidney of a patient with HLH, may have contributed to renal dysfunction manifest as proteinuria.
Literature
1.
go back to reference Maakaroun NR, Moanna A, Jacob JT, Albrecht H. Viral infections associated with haemophagocytic syndrome. Rev Med Virol. 2010;20:93–105.PubMedCrossRef Maakaroun NR, Moanna A, Jacob JT, Albrecht H. Viral infections associated with haemophagocytic syndrome. Rev Med Virol. 2010;20:93–105.PubMedCrossRef
2.
go back to reference Scott R, Robb-Smith AHT. Histiocytic medullary reticulosis. Lancet. 1939;2:194–8.CrossRef Scott R, Robb-Smith AHT. Histiocytic medullary reticulosis. Lancet. 1939;2:194–8.CrossRef
3.
go back to reference Gupta S, Weitzman S. Primary and secondary hemophagocytic lymphohistiocytosis: clinical features, pathogenesis and therapy. Expert Rev Clin Immunol. 2010;6:137–54.PubMedCrossRef Gupta S, Weitzman S. Primary and secondary hemophagocytic lymphohistiocytosis: clinical features, pathogenesis and therapy. Expert Rev Clin Immunol. 2010;6:137–54.PubMedCrossRef
4.
go back to reference Karras A. What nephrologists need to know about hemophagocytic syndrome. Nat Rev Nephrol. 2009;5:329–36.PubMedCrossRef Karras A. What nephrologists need to know about hemophagocytic syndrome. Nat Rev Nephrol. 2009;5:329–36.PubMedCrossRef
5.
go back to reference Henter JI, Horne A, Arico M, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48:124–31.PubMedCrossRef Henter JI, Horne A, Arico M, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48:124–31.PubMedCrossRef
6.
go back to reference Créput C, Galicier L, Buyse S, Azoulay E. Understanding organ dysfunction in hemophagocytic lymphohistiocytosis. Intensive Care Med. 2008;34:1177–87.PubMedCrossRef Créput C, Galicier L, Buyse S, Azoulay E. Understanding organ dysfunction in hemophagocytic lymphohistiocytosis. Intensive Care Med. 2008;34:1177–87.PubMedCrossRef
7.
go back to reference Karras A, Thervet E, Legendre C, groupe Cooperatif de transplantation d’Lle de France. Hemophagocytic syndrome in renal transplant recipients: report of 17 cases and review of the literature. Transplantation. 2004;77:238–43.PubMedCrossRef Karras A, Thervet E, Legendre C, groupe Cooperatif de transplantation d’Lle de France. Hemophagocytic syndrome in renal transplant recipients: report of 17 cases and review of the literature. Transplantation. 2004;77:238–43.PubMedCrossRef
8.
go back to reference Ponticelli C, Alberighi ODC. Haemophagocytic syndrome-a life-threatening complication of renal transplantation. Nephrol Dial Transplant. 2009;24:2623–7.PubMedCrossRef Ponticelli C, Alberighi ODC. Haemophagocytic syndrome-a life-threatening complication of renal transplantation. Nephrol Dial Transplant. 2009;24:2623–7.PubMedCrossRef
9.
go back to reference Li L, Okusa MD. Macrophages, dendritic cells and kidney ischemia-reperfusion injury. Semin Nephrol. 2010;30:268–77.PubMedCrossRef Li L, Okusa MD. Macrophages, dendritic cells and kidney ischemia-reperfusion injury. Semin Nephrol. 2010;30:268–77.PubMedCrossRef
10.
go back to reference Williams TM, Little MH, Ricardo SD. Macrophages in renal development, injury and repair. Semin Nephrol. 2010;30:255–67.PubMedCrossRef Williams TM, Little MH, Ricardo SD. Macrophages in renal development, injury and repair. Semin Nephrol. 2010;30:255–67.PubMedCrossRef
11.
go back to reference Matsumoto K, Fukuda N, Abe M, Fujita T. Dendritic cells and macrophages in kidney disease. Clin Exp Nephrol. 2010;14:1–11.PubMedCrossRef Matsumoto K, Fukuda N, Abe M, Fujita T. Dendritic cells and macrophages in kidney disease. Clin Exp Nephrol. 2010;14:1–11.PubMedCrossRef
12.
go back to reference Nahum E, Ben-Ari J, Stain J, Schonfeld T. Hemophagocytic lymphohistiocytic syndrome: unrecognized cause of multiple organ failure. Pediatr Crit Care Med. 2000;1:51–4.PubMedCrossRef Nahum E, Ben-Ari J, Stain J, Schonfeld T. Hemophagocytic lymphohistiocytic syndrome: unrecognized cause of multiple organ failure. Pediatr Crit Care Med. 2000;1:51–4.PubMedCrossRef
13.
go back to reference Thaunat O, Delahousse M, Fakhouri F, Martinez F, Stephan JL, Noel LH, Karras A. Nephrotic syndrome associated with hemophagocytic syndrome. Kidney Int. 2006;69:1892–8.PubMedCrossRef Thaunat O, Delahousse M, Fakhouri F, Martinez F, Stephan JL, Noel LH, Karras A. Nephrotic syndrome associated with hemophagocytic syndrome. Kidney Int. 2006;69:1892–8.PubMedCrossRef
14.
go back to reference Ardalan MR, Shoja MM, Tubbs RS, Esmaili H, Keyvani H. Postrenal transplant hemophagocytic lymphohistiocytosis and thrombotic microangiopathy associated with parvovirus b19 infection. Am J Transplant. 2008;8:1340–4.PubMedCrossRef Ardalan MR, Shoja MM, Tubbs RS, Esmaili H, Keyvani H. Postrenal transplant hemophagocytic lymphohistiocytosis and thrombotic microangiopathy associated with parvovirus b19 infection. Am J Transplant. 2008;8:1340–4.PubMedCrossRef
15.
go back to reference Ohga S, Matsuzaki A, Nishizaki M, et al. Inflammatory cytokines in virus-associated hemophagocytic syndrome. Interferon-gamma as a sensitive indicator of disease activity. Am J Pediatr Hematol Oncol. 1993;15:291–8.PubMed Ohga S, Matsuzaki A, Nishizaki M, et al. Inflammatory cytokines in virus-associated hemophagocytic syndrome. Interferon-gamma as a sensitive indicator of disease activity. Am J Pediatr Hematol Oncol. 1993;15:291–8.PubMed
16.
go back to reference Billiau AD, Roskams T, Van Damme-Lombaerts R, Matthys P, Wouters C. Macrophage activation syndrome: characteristic findings on liver biopsy illustrating the key role of activated, IFN-gamma-producing lymphocytes and IL-6 and TNF-alpha-producing macrophages. Blood. 2005;10:1648–51.CrossRef Billiau AD, Roskams T, Van Damme-Lombaerts R, Matthys P, Wouters C. Macrophage activation syndrome: characteristic findings on liver biopsy illustrating the key role of activated, IFN-gamma-producing lymphocytes and IL-6 and TNF-alpha-producing macrophages. Blood. 2005;10:1648–51.CrossRef
Metadata
Title
Glomerular hemophagocytic macrophages in a patient with proteinuria and clinical and laboratory features of hemophagocytic lymphohistiocytosis (HLH)
Authors
Ling Cao
William Dean Wallace
Shahrooz Eshaghian
Yuliya Linhares
Victor J. Marder
Publication date
01-11-2011
Publisher
Springer Japan
Published in
International Journal of Hematology / Issue 5/2011
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1007/s12185-011-0936-2

Other articles of this Issue 5/2011

International Journal of Hematology 5/2011 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine